Posted on August 5, 2021
Congratulations to Michael T. Lotze, MD, who has been selected to receive the 2021 Lifetime Achievement Award from the Society for Immunotherapy for Cancer (SITC) in recognition of his outstanding service and leadership and dedication to advancing the society’s mission and vision.
The award recognizes an outstanding SITC member or collaborator who has made a significant impact on SITC’s development and mission. This award will be presented as part of SITC’s Annual Awards, which recognize and honor those who have given tirelessly to the field of cancer immunotherapy and to the SITC.
Dr. Lotze will be recognized as the recipient of the award at SITC’s 36th Annual Meeting in Washington DC, Nov. 12-14, 2021.